The new systems will change the way medications are ordered, labeled, stored, distributed and administered. UVA is working with four leading healthcare technology and service organizations to move from a centralized system, where a large number of medications are delivered on carts from the central pharmacy, to a decentralized medication distribution model.
University of Virginia Professor of Medicine Thomas Platts-Mills, MD, PhD, has achieved the rare distinction of being elected a Fellow of the Royal Society for his research into the causes of asthma and allergic disease.
Criminal poisoning cases can be hard to recognize and even harder to solve when law enforcement officials don't know what a poisoning looks like. "Criminal Poisoning: Clinical and Forensic Perspectives" contains information for law enforcement, attorneys and medical providers to use when investigating cases of suspected criminal poisonings.
UVA is encouraging all adults to complete an advance directive, a document that allows adults to specify what kinds of medical treatments they would want and who they would want making decisions about their care if they were unable to make decisions for themselves.
The unique device, the dual modality tomographic (DMT) breast scanner, developed by UVA researchers, has shown in its pilot study the ability to pinpoint to a much finer degree the exact location of breast masses, and to more accurately distinguish between cancerous and harmless lesions.
The Renal Physicians Association has recognized the staff of the University of Virginia's Amherst Dialysis clinic with its second annual End Stage Renal Disease Patient Safety Improvement Award.
UVA is offering the latest and most advanced technology in stereotactic radiosurgery, called Gamma Knife eXtend™, which allows physicians to treat larger tumors, multiple tumors and tumors near sensitive structures like the brainstem, facial nerves or the optic nerve.
The University of Virginia (UVA) in Charlottesville today announced that it has entered into a research collaboration with Merck (known as MSD outside the United States and Canada) to discover novel drugs for women's reproductive health.
A new home test kit based on a protein in sperm discovered by a University of Virginia Health System cell biologist can assist couples in determining if a man's sperm count is normal, low, or very low.
Brian H. Annex, M.D., chief of the Division of Cardiovascular Medicine in the Department of Medicine at the University of Virginia Health System, is available to speak about Clinton’s procedure and the signs and symptoms of heart disease that should not be ignored. Annex's clinical and research areas include a focus on peripheral arterial disease (PAD) where blockages in arteries cause illness and ongoing problems.
The Sports Medicine Clinic at the University of Virginia Health System is using a cutting-edge therapy called platelet rich plasma (PRP) to help heal injured ligaments, tendons and muscles. PRP therapy has gained some national media attention because of its use in high-profile, professional athletes.
Based on a true story, the film "Extraordinary Measures" highlights a condition called Pompe disease. Shawn Lipinski, a certified genetic counselor at the University of Virginia Children’s Hospital, works with Pompe disease patients and is available to discuss this condition.
Dr. Michel Kahaleh is the only physician in Virginia currently using probe-based confocal laser endomicroscopy (pCLE). pCLE is a technique that lets him view live tissue in real time at the cellular level. This allows the identification of cancer with pinpoint precision and permits precise removal of the diseased tissue.
Researchers at the University of Virginia Health System have developed a promising x-ray free technique to treat a common heart disorder called atrial fibrillation – a breakthrough that could all but eliminate potentially dangerous radiation exposure to patients and their medical providers.
Three UVA cardiologists won K23 grants, which provide support for three to five years of mentored study and research.
The UVA Health House project consists of two structurally-adapted and specially-equipped residences from which occupants can routinely transmit vital signs and other medical readings to remote caregivers. When readings are abnormal, caregivers can intervene before a patient becomes seriously ill.
When the UVA Health System’s new Club Red Clinic was on the drawing board, its organizers envisioned creating an innovative, cost-effective model for healthcare delivery. They decided to meld two timely healthcare concepts – prevention and shared medical appointments (SMAs) – into a unique clinical offering that has garnered overwhelmingly positive feedback from patients.
Previous research has demonstrated links between urban sprawl and many of our most pressing public health issues, including obesity and traffic injuries. New research from the University of Virginia Health System shows that urban sprawl also causes delays in ambulances reaching their destinations in sprawling sections of large metropolitan areas in the United States.
During a recent visit to UVA Medical Center, heart transplant recipient Anne Kirchmeir surprised her cardiologist, James Bergin, M.D., with a gift – one of the three gold medals she won during track events at this summer’s World Transplant Games in Gold Coast, Australia.
Cancer patients don’t have time to waste, yet many must endure a process of elimination as physicians try different treatments until identifying the one most effective against their particular type of tumor. Now researchers at the UVA Health System have developed a breakthrough method that could one day eliminate this approach to treating many cancers.
UVA professor of neurosurgery Neal Kassell believes that MRgFUS - the technological marriage of magnetic resonance imaging and focused ultrasound - may be the most important therapeutic development since the scalpel. That notion will soon be explored by dozens of his colleagues from nine specialties who will engage in a robust program of research projects and clinical trials at UVA's new Focused Ultrasound Center, which was dedicated on September 14.
To address a consumer trend that is gaining momentum, the Ethics, Law and Humanities Committee of the American Academy of Neurology (AAN) has released a special report, “Responding to requests from adult patients for neuroenhancements,” which was published in the September 23, 2009, online issue of Neurology, the medical journal of the AAN.
During EECP therapy, patients lie flat on a treatment table and wear inflatable cuffs around their calves, lower thighs and upper thighs. A computer inflates and deflates the cuffs in sync with a patient’s heartbeat for 60 minutes. The cuffs inflate during the heart’s resting phase, forcing blood back into the heart and reducing its workload.
UVA's Dr. David Burt has developed and refined project UPSTART , which combines medical best practices with the principles of systems engineering and crisis management. The program, which Burt is sharing with other hospitals at no cost, is now helping ER staffs around the country optimize their processes for diagnosing and treating patients who are having a STEMI.
Located on the grounds of the UVA Health System, the new center will launch a robust, multi-disciplinary research program to investigate the safety and efficacy of MR Guided Focused Ultrasound in treating brain, breast, prostate, bone and liver tumors and conditions such as epilepsy, stroke, chronic pain, Parkinson’s disease and essential tremor.
Researchers at the University of Virginia Health System mapped out a three-dimensional structure of the enzyme protein BA2930, which is produced by the bacteria responsible for anthrax, Bacillus anthracis. They did so by using X-ray crystallography, a technique that provides a three-dimensional snapshot of the arrangement of atoms in a protein.
University of Virginia researchers used newly-developed MRI and MRS methods to assess 85 patients with mild-to-moderate peripheral artery disease who experienced intermittent leg pain while walking. A key finding is that walking abilities in PAD patients could be improved by separate therapies aimed at increasing blood flow and metabolism.
Nearly 250 volunteers from the University of Virginia Health System are en route today to the nation's largest free healthcare event, the Remote Area Medical clinic in Wise, Va. Within hours of their arrival, the volunteers will set up a multi-disciplinary medical clinic, lab and pharmacy to serve thousands of Americans in need.
Because UVA is one of several dozen U.S. medical centers researching the use of a new, minimally-invasive mitral valve repair procedure, George Forschler did not have to undergo open heart surgery when his leaky mitral valve caused him to become severely ill. The new procedure allows patients to heal faster with fewer complications.
For University of Virginia nursing and medical students, volunteering at the Remote Area Medical (RAM) clinic in Wise County, Va. will be more than an opportunity to provide much-needed care to an underserved population. It's also an opportunity to hone their clinical skills in an area that suffers greater nursing and physician shortages compared with most of the nation.
Wladek Minor, PhD, and his research team at the University of Virginia Health System are celebrating the attainment of an important milestone by the Midwest Center for Structural Genomics (MCSG), an international scientific consortium of which they are part.
The estimated one-third of adults who suffer from insomnia could soon find effective treatment without ever leaving their homes. Researchers at the University of Virginia Health System have developed a unique Internet-based intervention, based on well-established face-to-face cognitive behavioral therapy techniques, that has shown remarkable results in improving patients' sleep.
Sarah Anderson, PhD, forensic nurse in the Department of Emergency Medicine at the University of Virginia Health System, is part of a team that will travel to the Democratic Republic of Congo to educate clinicians on collecting evidence and providing care for the overwhelming number of rape victims they see daily. They will depart July 7 and return July 23.
Low level light therapy (LLLT) holds potential for improving neuronal cell function in patients with Parkinson's Disease (PD), according to a new study from the University of Virginia Health System.
The University of Virginia Health System anticipates a substantial increase in the number of people seeking free care at the annual Remote Area Medical (RAM) Clinic in Wise, Va. The clinic, which treated more than 2,600 patients last year, will be held July 24-26 at the Virginia-Kentucky Fairgrounds.
Researchers at the University of Virginia Health System have found a new way to study how genes function in living organisms, and their approach could substantially cut the time and costs that drug makers spend in searching for potential targets for new cancer therapies.
Michael Ragosta, M.D., Director of Cardiac Catheterization Laboratories and Director of Interventional Cardiology at the University of Virginia Health System, recommends that patients considering elective angioplasty do their homework before deciding to proceed.
Dr. Scott Strayer, University of Virginia physician and researcher, received $1.3 million from the National Institute on Drug Abuse, part of the National Institutes of Health, to further develop and evaluate an online smoking cessation tool that puts information and counseling techniques in the hands of primary care physicians"”literally.
Researchers at the University of Virginia Health System are reporting remarkable results from their pilot clinical study of the artificial pancreas, a computerized, subcutaneous system that could one day revolutionize the way Type 1 diabetics manage their disease.
The Kluge Children's Rehabilitation Center has been designated the state lead center in Virginia for the Sarah Jane Brain Project (SJBP)"” a national initiative formed to develop and implement a national Pediatric Acquired Brain Injury (PABI) Plan.
Motivated by a desire to understand why sudden cardiac death claims the lives of women under 60 at twice the rate of their male counterparts, Angela M. Taylor, M.D., an interventional cardiologist at the University of Virginia Health System, is launching a unique study that will color-code and measure plaque deposits inside the coronary arteries of male and female patients between the ages of 18 and 50.
UVA's Center for Research in Contraceptive and Reproductive Health is planning to fill three paid internships in contraceptive research and development with a high school student, a college undergraduate and a science educator, respectively.
A new study from the University of Virginia Health System has found that academic researchers who are highly reliant on industry support are most likely to have experienced questionable pressure from sponsors and to have first-hand knowledge of integrity breeches within their work environment.
The Pain Medicine Service, a division of the Department of Anesthesiology at the University of Virginia Health System, has received the prestigious 2009 Clinical Center of Excellence Award from the American Pain Society (APS) for providing outstanding, exemplary patient care.
New research from the University of Virginia Health System shows that, when combined, two emerging medical technologies hold significant promise for treating the most deadly and devastating form of brain tumor, glioblastoma multiforme (GBM).
New NIH-funded research from the University of Virginia Health System suggests that it is wise to be wary of the seed tick because its bite may set off a cascade of events that not only defy current thinking about food allergies, but also create serious health risks for people with certain blood types.
A medical home test kit based on a protein discovered at the University of Virginia Health System "“ SpermCheck Vasectomy "“ has begun shipping to zip codes across the U.S., marking the launch of a new product line that could revolutionize the way men around the world monitor their reproductive status.
David Schiff, M.D., and colleagues at the UVA Cancer Center were key researchers in a large national clinical trial that has resulted in FDA accelerated approval of the medication bevacizumab, or Avastin, to treat the recurrence of glioblastoma. Glioblastoma is the most aggressive malignant primary brain tumor in adults and is nearly always fatal.
The Chronic Obstructive Pulmonary Disease (COPD) program at the University of Virginia Health System has become the nation's second recipient of the Joint Commission's Certificate of Distinction for COPD. A widely-recognized symbol of quality, Joint Commission certification signifies that COPD care at UVA meets high national standards.
In a literature review, Fern Hauck, M.D., found that the highest level of evidence shows that giving an infant a pacifier does not interfere with breastfeeding success.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right